Ortivus AB (publ) (STO:ORTI.B)
Sweden · Delayed Price · Currency is SEK 1.970
+0.010 (0.51%)
Aug 12, 2026, 11:57 AM CET
Ortivus AB Revenue
Ortivus AB had revenue of 21.49M SEK in the quarter ending March 31, 2026, with 18.44% growth. This brings the company's revenue in the last twelve months to 76.75M, up 0.32% year-over-year. In the year 2025, Ortivus AB had annual revenue of 73.40M, down -8.72%.
Revenue (ttm)
76.75M
Revenue Growth
+0.32%
P/S Ratio
2.27
Revenue / Employee
2.26M
Employees
34
Market Cap
174.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.40M | -7.01M | -8.72% |
| Dec 31, 2024 | 80.41M | -3.67M | -4.36% |
| Dec 31, 2023 | 84.08M | -20.43M | -19.55% |
| Dec 31, 2022 | 104.51M | 10.24M | 10.86% |
| Dec 31, 2021 | 94.27M | -13.31M | -12.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AddLife AB | 10.53B |
| Synsam AB | 7.13B |
| Dynavox Group AB | 2.54B |
| Bonesupport Holding AB | 1.29B |
| Stille AB | 679.58M |
| Bio-Works Technologies AB | 82.85M |
| S2Medical AB | 16.13M |
| iZafe Group AB | 7.09M |
Ortivus AB News
- 3 months ago - Ortivus AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Ortivus AB Annual report: Q4 2025 - Filings
- 6 months ago - Ortivus AB Quarterly report: Q4 2025 - Filings
- 9 months ago - Ortivus AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Ortivus AB Quarterly report: Q2 2025 - Filings